Compare Heron Therapeutics Inc (HRTX) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Omnicom Group Inc. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Omnicom Group Inc. trades at $79.22 (market cap $23.48B). The key difference: Omnicom Group Inc. is far larger — about 256.7× Heron Therapeutics Inc's market cap, and Omnicom Group Inc. pays a 3.88% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | OMC | |
|---|---|---|
Market Cap | $91.46M | $23.48B |
Sector | Health | Media |
52-Week High | $1.96 | $85.80 |
52-Week Low | $0.39 | $67.27 |
Enterprise Value | $189.36M | $30.70B |
Dividend Yield | — | 3.88% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
